DNB//Back Bay Investor Day - Nordic-American Healthcare Conference 2023
For eight years, the DNB Nordic-American Healthcare Conference (formerly the Nordic American Life Science Conference) has been the leading US forum for US-Nordic healthcare investment and growth, bringing together promising Nordic innovation from biopharma, medtech, healthtech, and health services companies to US investors, healthcare partners, colleagues, and friends. We are proud to bring the best of Nordic healthcare to the world and to New York City.
This year’s conference is planned for December 6-7, 2023, in New York City.
The two-day event includes expert panel discussions addressing challenges across drug development, healthtech, commercialization, and the M&A and public market performance that impact investment returns across geography, sector, and stage, along with presentations by leading, late-stage private and mid- to large-cap public Nordic companies ready for US and global investor and BD collaboration. Attendees will also hear from global public companies with dominant roles in drug development, medical and health technologies, public market dynamics, and the acquisition markets.
DNB//Back Bay is pleased to present this special event in New York City, with two days of presentations, industry discussions, networking, and special receptions. Qualified investors and BD are encouraged to reserve their seat early and meet with companies including:
